Renzenbrink & Partner advises funds advised by IK Investment Partners (IK VIII Funds) on the acquisition of KLINGEL Group
30. May 2018IK Investment Partners (VIII Funds) has signed an agreement with Halder to acquire the KLINGEL Group (KLINGEL Beteiligungs GmbH, KLINGEL medical metal GmbH and Josef Ganter GmbH), a leading manufacturer of high-precision, complex metal components for medical technology. The transaction is still subject to approval by the German Federal Cartel Office.
KLINGEL was founded in 1986 and is a leading independent specialist in the manufacture of high-precision titanium and high-quality stainless steel components. The high-quality products are used for numerous orthopaedic, cardiovascular and dental implants as well as for endoscopy, dialysis and robotic surgery instruments. KLINGEL supports its customers in all phases of the development process, from design and prototype development to production, packaging and logistics. KLINGEL operates two production facilities in Pforzheim, Germany, and employs over 300 people.
IK and the company’s management team will continue to build on its strong market position, technical expertise and comprehensive customer service offering to deliver value to end users. In particular, IK will leverage its considerable expertise in the Contract Manufacturing Organization (CMO) market to support the company in pursuing an international growth strategy for its premium quality products.
Renzenbrink & Partner advised IK on all legal and tax aspects of the transaction. The Renzenbrink & Partner team consisted of Dr. Ulf Renzenbrink (Private Equity/M&A), Marc H. Kotyrba (Tax), Dr. Andreas Stoll (Private Equity/M&A), Dr. Gunnar L. Schmüser (Finance), Florian Seitz (Tax), Dr. Alexander Haunschild and Martin Degenhard (both Private Equity/M&A).